Journal for ImmunoTherapy of Cancer (Nov 2023)
328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)